Loading...
Risk management of biosimilars in oncology: each medicine is a work in progress
Drug licensing and drug safety monitoring for standard chemical entities have been established and are routinely used. These have resulted in a solid foundation of knowledge from which confident therapeutic decisions can be made. For many chemical entities, this advanced level of experience is also...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer-Verlag
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3291842/ https://ncbi.nlm.nih.gov/pubmed/22274817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-011-0188-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|